申请人:ELI LILLY AND COMPANY
公开号:US10278970B2
公开(公告)日:2019-05-07
The present invention provides compounds of the formula below
pharmaceutically acceptable salts of the compounds, methods of treating patients for liver disease, and processes for preparing the compounds.
本发明提供下式化合物
这些化合物的药学上可接受的盐、治疗肝病患者的方法以及制备这些化合物的工艺。